Defense World
20 Dec 2025, 08:27 UTC · 39w ago
Verdict
Headline takes no side. We score STOK +0.50 across two claims — strongly bullish.
+0.50strongly bullish
More positive than 68% of ticker scores this week
What the story claims
2 claims · scored −1 bearish … +1 bullish
Assenagon Asset Management S.A. increased its position in Stoke Therapeutics (STOK) by 67.3% during the third quarter.
So whatSignificant accumulation by an institutional manager typically signals confidence in the company's pipeline or valuation, though a single fund's move has limited systemic impact.
More positive than 63% of claims this week
Assenagon Asset Management's total holding in Stoke Therapeutics reached 900,272 shares following the purchase of 362,299 additional shares.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
More positive than 42% of claims this week
Which stocks this story touches
More positive than 68% of ticker scores this week
A major institutional investor significantly increased its position in the company by over 67%.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
CNBC
2h ago
−18.3%
Price is moving against the score
$26.11 vs $31.96 close before publication (Dec 19) · not market-adjusted
STOK chart →
